Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis

Arash Afshari; Jørn Wetterslev; Jesper Sune Brok; Ann Møller

doi:10.1136/bmj.39398.682500.25

Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis

Arash Afshari, Jørn Wetterslev, Jesper Sune Brok, Ann Møller

81 Citationer (Scopus)

Abstract

To evaluate the benefits and harms of antithrombin III in critically ill patients.

Originalsprog	Engelsk
Tidsskrift	B M J
Vol/bind	335
Udgave nummer	7632
Sider (fra-til)	1248-51
Antal sider	4
ISSN	0959-8146
DOI	https://doi.org/10.1136/bmj.39398.682500.25
Status	Udgivet - 15 dec. 2007

Adgang til dokumentet

10.1136/bmj.39398.682500.25

Citationsformater

@article{2d463907570e4236b6b79631cf7c7de5,

title = "Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis",

abstract = "To evaluate the benefits and harms of antithrombin III in critically ill patients.",

keywords = "Anticoagulants, Antithrombin III, Critical Illness, Humans, Intensive Care, Length of Stay, Quality of Life, Randomized Controlled Trials as Topic, Respiration, Artificial, Risk Factors",

author = "Arash Afshari and J{\o}rn Wetterslev and Brok, {Jesper Sune} and Ann M{\o}ller",

year = "2007",

month = dec,

day = "15",

doi = "10.1136/bmj.39398.682500.25",

language = "English",

volume = "335",

pages = "1248--51",

journal = "B M J",

issn = "0959-8146",

publisher = "B M J Group",

number = "7632",

}

TY - JOUR

T1 - Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis

AU - Afshari, Arash

AU - Wetterslev, Jørn

AU - Brok, Jesper Sune

AU - Møller, Ann

PY - 2007/12/15

Y1 - 2007/12/15

N2 - To evaluate the benefits and harms of antithrombin III in critically ill patients.

AB - To evaluate the benefits and harms of antithrombin III in critically ill patients.

KW - Anticoagulants

KW - Antithrombin III

KW - Critical Illness

KW - Humans

KW - Intensive Care

KW - Length of Stay

KW - Quality of Life

KW - Randomized Controlled Trials as Topic

KW - Respiration, Artificial

KW - Risk Factors

U2 - 10.1136/bmj.39398.682500.25

DO - 10.1136/bmj.39398.682500.25

M3 - Review

C2 - 18037615

SN - 0959-8146

VL - 335

SP - 1248

EP - 1251

JO - B M J

JF - B M J

IS - 7632

ER -

Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater